Key Takeaways: The clinical average TRT dose is 100-200 mg/week of testosterone cypionate or enanthate, with most men settling at 120-140 mg/week. But "average" hides a wide distribution. Many men feel best at 25-50 mg/week. Others genuinely need 180-200 mg/week to hit target free T. The right dose is not the average dose — it is your lowest effective dose, determined by 6-8 week labs plus how you actually feel.
The Real Answer to "What Is the Average?"
Published studies and clinical survey data converge on a range rather than a single number:
- VA prescribing patterns: mean weekly dose 140 mg, majority in 100-180 mg range
- Endocrinology practices: mean weekly dose 100-140 mg
- Cash-pay telehealth TRT clinics: mean weekly dose 140-180 mg, significant portion at 200 mg
- Independent compounding-based programs: mean weekly dose 120-160 mg
Call it 100-200 mg/week with a center of gravity around 120-160. That is the "average."
What you actually need, though, depends on four variables:
- Your SHBG level (binds testosterone; higher SHBG means you need more total T to hit a free T target)
- Your baseline suppression (severely suppressed men may need more early, less later)
- Your sensitivity to androgens (some men respond big to small doses)
- Your goals (pure symptom relief vs. performance-oriented replacement)
The Dose Distribution
If you polled 1,000 men on TRT and plotted their weekly doses, the curve would look roughly like this:
| Weekly Dose | Approximate % of Users | Typical Profile |
|---|---|---|
| 25-50 mg | 5-10% | Start-low protocols, low SHBG, high androgen sensitivity |
| 60-90 mg | 10-15% | Mild baseline low T, normal SHBG, minimum effective dose approach |
| 100-140 mg | 35-45% | Standard replacement, most common band |
| 150-180 mg | 20-25% | Higher SHBG, performance-oriented, athletic demands |
| 200 mg+ | 10-15% | Aggressive telehealth defaults, low responders, supraphysiologic goals |
Most men are somewhere in the middle two rows. If you are at 200 mg/week and feeling great, that is fine — but it is not the population average and it is not a universal starting point.
Why Clinics Prescribe Different Defaults
The range of clinic defaults tells you something important: dosing culture is not just clinical, it is institutional.
Conservative Endocrinology: 80-120 mg/week default
- Priority: minimum effective dose, long-term safety
- Philosophy: start low, adjust up based on labs
- Typical patient: insurance-based, longer lab cycles, less frequent titration
Mid-range Telehealth: 120-160 mg/week default
- Priority: balance symptom relief and safety
- Philosophy: normal starting replacement dose, adjust at 6-8 weeks
- Typical patient: cash-pay, wants clear results in 3 months, willing to titrate
Aggressive Telehealth: 180-200 mg/week default
- Priority: fast symptom relief, high retention
- Philosophy: push levels above mid-range quickly, manage side effects later
- Typical patient: cash-pay, wants max benefit, often lifts or has athletic goals
None of these are inherently wrong. But the default dose your clinic uses says a lot about whether they prioritize your long-term lowest effective dose or your first-month experience.
The Start-Low Angle
The "start low" approach. Standard TRT is often prescribed at 100-200mg/week from day one — doses calibrated to push levels well above mid-range fast. For some users, that jump is too much: energy spikes, mood swings, aggression, sleep disruption. A conservative approach starts at 25-50mg/week (~1/4 the standard dose) for 4-8 weeks, then titrates up only if blood work and symptoms warrant it. Many users find they never need the full dose — they hit target free T levels and meet their goals without the "overly pumped up" feeling higher doses produce. Ask your prescriber about a slow-titration schedule if this matches how you want the adjustment to feel.
Why 1/4 Dose Often Works Better Than People Expect
A common pattern in men who try a start-low protocol:
- Week 2-3: subtle mood and sleep improvement
- Week 4: libido returns without the week-3 spike effect
- Week 6-8: first labs often show total T 500-700 ng/dL and free T 12-18 pg/mL — already inside the optimal range for many men
- Month 3: stable, symptoms resolved, no obvious need to increase
The reasons this works for more men than clinical defaults suggest:
- Androgen receptor sensitivity upregulates at lower doses. Chronic high-dose testosterone downregulates receptors. Conservative doses do not.
- Pharmacokinetic stability at low doses is excellent. 25 mg x 2/week produces a remarkably flat curve.
- Fewer E2 management problems. Aromatization is dose-dependent. Lower T in, less E2 out, fewer follow-on issues.
- Hematocrit stays flat. The polycythemia risk scales with dose. Men on 50 mg/week rarely see hematocrit concerns.
- Libido tends to be more stable. High-dose libido spikes often reverse as E2 climbs. Lower doses avoid the cycle.
This is not a universal recommendation. Men with severe hypogonadism (total T <200, symptom-heavy) often need a higher starting dose to feel functional within weeks. But for men with borderline or mildly low levels — 250-450 ng/dL — starting at 25-50 mg/week is defensible, well-tolerated, and often produces better long-term results.
